Barchart.com
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Leap Therapeutics Inc (LPTX)

Leap Therapeutics Inc (LPTX)
0.3605 -0.0085 (-2.30%) 15:48 ET [NASDAQ]
0.3583 x 2 0.3610 x 4
Realtime by (Cboe BZX)
0.3583 x 2 0.3610 x 4
Realtime - - (-) -
News & Headlines for Thu, Apr 17th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe Stocktwits - Wed Feb 12, 10:32AM CST

KURA : 5.89 (+2.43%)
SHPH : 0.2488 (-2.81%)
LPTX : 0.3605 (-2.30%)
NXTC : 0.3650 (+9.02%)
ACET : 0.5267 (-7.81%)
Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline Stocktwits - Tue Jan 28, 1:24PM CST

While sirexatamab combined with tislelizumab and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival endpoints....

PINK : 27.93 (-0.32%)
IWC : 104.28 (+1.11%)
VXF : 161.94 (+0.80%)
LPTX : 0.3605 (-2.30%)
Leap Therapeutics Reports Second Quarter 2023 Financial Results PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

LPTX : 0.3605 (-2.30%)
Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients PR Newswire - Wed Jul 12, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

LPTX : 0.3605 (-2.30%)
Leap Therapeutics Announces Reverse Stock Split PR Newswire - Tue Jun 20, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

LPTX : 0.3605 (-2.30%)
Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting PR Newswire - Thu May 25, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

LPTX : 0.3605 (-2.30%)
Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting PR Newswire - Wed Apr 26, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

LPTX : 0.3605 (-2.30%)
Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients PR Newswire - Wed Apr 12, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

LPTX : 0.3605 (-2.30%)
Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire - Fri Mar 24, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

LPTX : 0.3605 (-2.30%)
Leap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01 PR Newswire - Thu Mar 16, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

LPTX : 0.3605 (-2.30%)

Barchart Exclusives

Should You Buy Tesla Stock Before April 22? Barchart - 29 minutes ago
The electric vehicle maker is scheduled to report first-quarter results next week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro
Wed, Apr 23, 2025 5:00 PM UTC
Reserve Your Spot